Getting Zanzalintinib (XL092) Covered by Humana in Texas: Appeals Process and State Protections
Quick Answer: Getting Zanzalintinib (XL092) Covered by Humana in Texas
Zanzalintinib (XL092) is an investigational drug typically denied by Humana outside clinical trials. However, Texas law provides strong appeal rights for investigational treatments. Your fastest path: Request a formulary exception with clinical documentation, then if denied, file for Texas Independent